Ko 143

Ko 143 Structure
CAS No.
461054-93-3
Chemical Name:
Ko 143
Synonyms
Ko 143;12aS)-;4-dioxo-;6]pyrido[3;Ko143 ,99%;Pyrazino[1';Ko143 hydrate;KO 143;KO-143;KO143;4-b]indole-3-propanoicacid;12a-octahydro-9-Methoxy-6-(2-Methylpropyl)-1
CBNumber:
CB81562442
Molecular Formula:
C26H35N3O5
Molecular Weight:
469.57
MOL File:
461054-93-3.mol
MSDS File:
SDS
Modify Date:
2024/11/16 15:32:52

Ko 143 Properties

Melting point 147 ºC
Boiling point 689.8±55.0 °C(Predicted)
Density 1.24
storage temp. Desiccate at -20°C
solubility DMSO: >10mg/mL
form powder
pka 13.31±0.60(Predicted)
color white to off-white
Stability Stable for 2 years from date of purchase as supplied. Protect from exposure to moisture. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P261-P305+P351+P338
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36
WGK Germany  3
NFPA 704
0
2 0

Ko 143 price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) K2144 Ko143 hydrate ≥98% (HPLC) 461054-93-3 1MG ₹12697.73 2022-06-14 Buy
Sigma-Aldrich(India) K2144 Ko143 hydrate ≥98% (HPLC) 461054-93-3 5MG ₹50379.55 2022-06-14 Buy
Product number Packaging Price Buy
K2144 1MG ₹12697.73 Buy
K2144 5MG ₹50379.55 Buy

Ko 143 Chemical Properties,Uses,Production

Description

Breast cancer resistance protein (BCRP) is an ATP-binding cassette protein known also as ABCG2. While it normally functions as a high-capacity urate exporter in the renal system, it also acts as a xenobiotic transporter and contributes to multidrug resistance (e.g., to mitoxantrone) in certain types of cancer. BCRP is abundant at the intestinal epithelium and blood-brain barrier, potentially restricting the distribution of certain drugs. Ko 143 is a potent and selective inhibitor of BCRP, preventing the export of mitoxantrone and topotecan in breast cancer cell lines (EC50s = 23 and 26 nM, respectively). It is much less effective at the transporters P-glycoprotein and multidrug resistance-associated protein 1, MRP1. Ko 143 is effective in vivo in mice.

Uses

A potent BCRP (breast cancer resistance protein) inhibitor

Biological Activity

Potent and selective breast cancer resistance protein multidrug transporter (BCRP) inhibitor (EC 90 = 26 nM). Displays > 200-fold selectivity over P-gp and MRP-1 transporters. Increases intracellular drug accumulation and reverses BCRP-mediated multidrug resistance.

Ko 143 Preparation Products And Raw materials

Raw materials

Preparation Products

Ko 143 Suppliers

Global( 98)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39894 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49374 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29811 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10473 58 Inquiry
TargetMol Chemicals Inc. United States 38470 58 Inquiry
HangZhou RunYan Pharma Technology Co.,LTD. +8618882027439 China 302 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 57505 58 Inquiry
Amadis Chemical Company Limited 571-89925085 China 131957 58 Inquiry
Shanghai Zeye Biotechnology Co., Ltd. 021-61998551 13122364865 China 9772 58 Inquiry
Jiangxi Jianglan Pure Biological Reagent Co., Ltd. 021-54720761 CHINA 6134 58 Inquiry

Ko 143 Spectrum

Pyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid, 1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxo-, 1,1-dimethylethyl ester, (3S,6S,12aS)-(Ko143) Ko 143 (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester 12a-octahydro-9-Methoxy-6-(2-Methylpropyl)-1 12aS)- 4-b]indole-3-propanoicacid 4-dioxo- 6]pyrido[3 Pyrazino[1' Ko143 ,99% Ko143 hydrate tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7, 12,12a-octahydropyrazino[1 (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-( 2-methylpropyl)-1,4-dioxopyrazino[1′,2′:1,6]pyrido[3,4- b]indole-3-propanoic acid 1,1-dimethylethyl ester hydrate tert-butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)propanoate KO 143;KO-143;KO143 tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2' 1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester (3s,6s,12as)-1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester tert-Butyl 3-((3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)propanoate (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-( 2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4- b]indole-3-propanoic Acid tert-Butyl Ester 461054-93-3 C26H35N3O5 C26H36N3O5 Pharmaceuticals Chiral Reagents Heterocycles Inhibitors Intermediates & Fine Chemicals